levodopa has been researched along with Depressive Disorder in 81 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (33.33) | 18.7374 |
1990's | 23 (28.40) | 18.2507 |
2000's | 18 (22.22) | 29.6817 |
2010's | 13 (16.05) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bichon, A; Broussolle, E; Carnicella, S; Castrioto, A; Delpont, B; Fraix, V; Kistner, A; Klinger, H; Krack, P; Lhommée, E; Lüscher, C; Pélissier, P; Pollak, P; Quesada, JL; Schmitt, E; Thobois, S | 1 |
Cao, B; Chen, Y; Hou, Y; Liu, H; Ou, R; Shang, H; Song, W; Wei, Q; Yuan, X; Zhang, L | 1 |
Akyildiz, U; Akyol, A; Dogan, B; Memis, CO; Sair, A; Sevincok, L | 1 |
Chen, S; Cui, S; Du, JJ; Fu, R; Gao, C; Huang, P; Lin, Y; Wang, T; Zhou, H | 1 |
Eggers, C; Horstkoetter, N; Kalbe, E; Kuhn, J; Lewis, CJ; Maarouf, M; Maier, F; Moro, E; Timmermann, L; Woopen, C; Zurowski, M | 1 |
Baybas, S; Dirican, A; Dogan, GB; Dogan, VB; Koksal, A | 1 |
Bingefors, K; Isacson, D; Kristiansen, IS; Nyholm, D | 1 |
García-Sánchez, C; Gironell, A; Kulisevsky, J; Martínez-Corral, M; Pagonabarraga, J; Pascual-Sedano, B | 1 |
Kulisevsky, J; Martinez-Corral, M; Pagonabarraga, J | 1 |
Chan, P; Fang, X; Liu, H; Qin, Z; Sun, F; Zhang, L | 1 |
Adam, OR; Ferrara, JM; Ondo, WG | 1 |
Dale, RC; Earl, J; Fung, VS; Grattan-Smith, P; Houlden, H; Melchers, A | 1 |
Amthauer, H; Assion, HJ; Beucke, JC; Endrass, T; Juckel, G; Kupsch, A; Plotkin, M; Uhl, I; Winter, C | 1 |
Bugalho, P; Cargaleiro, I; da Silva, JA; Neto, B; Serra, M | 1 |
Bloem, BR; Munneke, M; Petzinger, GM; Speelman, AD; van de Warrenburg, BP; van Nimwegen, M | 1 |
Antonini, A; Biundo, R; D'Avella, D; Ferla, S; Landi, A; Padoan, A; Pilleri, M | 1 |
Artigas, CF; Espino Ibáñez, A; Masmiquel Comas, L; Nicolau Ramis, J; Rivera Irigoín, R | 1 |
Bagheri, H; Montastruc, JL; Schmitt, L | 1 |
Jähnel, M | 1 |
Ishizu, H; Kuroda, S; Terada, S | 1 |
Allen, RC; Bakay, RA; Cornfeldt, ML; Raiser, CD; Schweikert, AW; Stover, NP; Subramanian, T; Watts, RL | 1 |
Duda, JE; Moberg, PJ; Morales, KH; Stern, MB; Weintraub, D | 1 |
Ardouin, C; Batir, A; Benabid, AL; Chabardès, S; Cools, R; Fraix, V; Funkiewiez, A; Krack, P; Pollak, P; Robbins, TW | 1 |
Bernardi, S; Meco, G | 1 |
Daniels, C; Deuschl, G; Herzog, J; Krack, P; Lorenz, D; Mehdorn, M; Reiff, J; Volkmann, J; Witt, K | 1 |
Alicock, LM | 1 |
Marinus, J; van Hilten, JJ; van Rooden, SM; Verbaan, D; Visser, M | 1 |
de Haan, RJ; Post, B; Speelman, JD | 1 |
Bria, P; Dario, T; Frustaci, A; Janiri, L; Martinotti, G; Pozzi, G; Reina, D | 1 |
Bitton, V; Melamed, E | 1 |
Linkowski, P; Mendlewicz, J | 1 |
Cooper, BR; Howard, JL; Soroko, FE | 1 |
Narabayashi, H | 1 |
Brauman, H; Linkowski, P; Mendlewicz, J | 1 |
Côté, L; Mayeux, R; Stern, Y; Williams, JB | 1 |
Coignet, A; de Recondo, J; Rondot, P; Ziegler, M | 1 |
Boni, B; Casacchia, M; Meco, G | 1 |
Klawans, HL | 1 |
Berezhnaia, VA; Nuller, IuL; Ostroumova, MN | 1 |
Calabrese, P; Durwen, HF; Gehlen, W; Holinka, B; Markowitsch, HJ | 1 |
Huszonek, JJ | 1 |
Caparros-Lefebvre, D; Duhamel, A; Pécheux, N; Petit, H; Petit, V | 1 |
Kathol, RG; Long, TD | 1 |
Jeanneau, A; Olie, JP | 1 |
Agren, H; Reibring, L | 1 |
Baas, H; Fischer, PA; Stecker, K | 1 |
Hesselink, JM | 1 |
Bowes, SG; Charlett, A; Dickins, J; Dobbs, RJ; Dobbs, SM; Frith, C; Henley, M | 1 |
López de Munain, A; Martí Massó, JF; Poza, JJ | 1 |
Simpson, JS | 1 |
Bowers, MB | 1 |
Nakajima, T | 1 |
Dobato, JL; Giménez-Roldán, S; Mateo, D | 1 |
Berger, M; Frauenknecht, S; Hesslinger, B; Normann, C; Walden, J | 1 |
Choi, C; Kim, J; Lee, JH; Sohn, YH | 1 |
Masson, C | 1 |
Linkowski, P; Mendlewicz, J; Van Cauter, E | 1 |
Brusov, OS; Lideman, RR | 1 |
Ashford, JW; Hargrave, R | 1 |
Manji, HK; Potter, WZ; Rudorfer, MV | 1 |
Bordet, R; Destée, A | 1 |
Cutlip, WD; Makela, EH | 1 |
Kuhn, W; Przuntek, H | 1 |
Garfinkel, BD; Jensen, JB | 1 |
Meltzer, HY; Parsa, MA; Ramirez, LF; Rohr, T | 1 |
Byerley, WF; Risch, SC | 1 |
Cote, L; Dyrenfurth, I; Frantz, A; Mayeux, R; Stern, Y; Williams, JB | 1 |
Arikawa, K; Inanaga, K; Kuniyoshi, M; Miura, C | 1 |
Douyon, R; Klutchko, B; Rotrosen, J; Serby, M | 1 |
Yu, PH | 1 |
Fahn, S | 1 |
Schnaberth, G | 1 |
Johansson, F; von Knorring, L | 1 |
Cummings, JL; Friedenberg, DL | 1 |
Birkmayer, W | 1 |
Battegay, R; Gastpar, M; Zmilacher, K | 1 |
Brown, RG; Gotham, AM; Marsden, CD; Nissenbaum, H; Quinn, NP; Toone, B | 1 |
Harvey, NS | 1 |
el-Awar, M; Freedman, M; Goldenberg, L; Little, J; Seeman, P; Solomon, P | 1 |
Cheng, SC; Diercks, MJ; Glaeske, C; Hsieh, HH; Jefferson, A; Pfeiffer, RF | 1 |
Jaeckle, RS; Nasrallah, HA | 1 |
13 review(s) available for levodopa and Depressive Disorder
Article | Year |
---|---|
How might physical activity benefit patients with Parkinson disease?
Topics: Antiparkinson Agents; Cardiovascular Diseases; Cognition; Constipation; Depressive Disorder; Dopamine; Humans; Levodopa; Motor Activity; Muscle Fatigue; Osteoporosis; Parkinson Disease; Psychomotor Performance; Quality of Life; Sedentary Behavior; Sleep Wake Disorders | 2011 |
[Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
Topics: Antidepressive Agents; Antiparkinson Agents; Bromocriptine; Citalopram; Depressive Disorder; Dopamine Agents; Female; Fluoxetine; Gambling; Humans; Levodopa; Middle Aged; Parkinson Disease | 2003 |
[Parkinson's disease].
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Cognition Disorders; Depressive Disorder; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Risk Factors; Selective Serotonin Reuptake Inhibitors | 2003 |
Managing patients with Parkinson's disease.
Topics: Antiparkinson Agents; Depressive Disorder; Disease Progression; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Patient Care Planning; Selective Serotonin Reuptake Inhibitors | 2007 |
[Neuroendocrinology of depressive disorders].
Topics: Adrenocorticotropic Hormone; Depressive Disorder; Dexamethasone; Dextroamphetamine; Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Levodopa; Melatonin; Periodicity; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1982 |
[Neuropsychological aspects in idiopathic Parkinson disease].
Topics: Aged; Brain Damage, Chronic; Dementia; Depressive Disorder; Humans; Levodopa; Neuropsychological Tests | 1995 |
Critical review of data supporting affective disorder caused by nonpsychotropic medication.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Bipolar Disorder; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Glucocorticoids; Histamine H2 Antagonists; Humans; Levodopa | 1993 |
[Depression in Parkinson disease. Clinical and etiopathogenic aspects].
Topics: Depressive Disorder; Humans; Levodopa; Parkinson Disease | 1994 |
[Drug treatment of frequent disorders in patients with Parkinson's disease].
Topics: Anticonvulsants; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Calcium Channel Blockers; Depressive Disorder; Humans; Levodopa; Parkinson Disease; Parkinson Disease, Secondary; Tranquilizing Agents | 1996 |
Amine precursor amino acid therapy: from neurochemical basis to clinical aspects.
Topics: 5-Hydroxytryptophan; Amino Acids; Animals; Depressive Disorder; Droxidopa; Histidine; Humans; Levodopa; Parkinson Disease | 1996 |
[From Parkinson's disease to Lewy body disease].
Topics: Alzheimer Disease; Dementia; Depressive Disorder; Humans; Levodopa; Lewy Bodies; Parkinson Disease | 1992 |
Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment.
Topics: 5-Hydroxytryptophan; Antidepressive Agents, Tricyclic; Blood Platelets; Brain Chemistry; Depressive Disorder; Female; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Levodopa; Male; Neurotransmitter Agents; Norepinephrine; Receptors, Neurotransmitter; Serotonin; Thyrotropin; Thyrotropin-Releasing Hormone; Tryptophan | 1985 |
Psychiatric disorders in parkinsonism. 1. Functional illnesses and personality.
Topics: Antidepressive Agents; Clozapine; Depressive Disorder; Dopamine; Electroconvulsive Therapy; Female; Homovanillic Acid; Humans; Levodopa; Male; Mental Disorders; Nomifensine; Nortriptyline; Parkinson Disease; Personality; Psychotic Disorders; Serotonin; Tryptophan | 1986 |
5 trial(s) available for levodopa and Depressive Disorder
Article | Year |
---|---|
Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion.
Topics: Aged; Antiparkinson Agents; Cross-Over Studies; Depressive Disorder; Disease Progression; Duodenum; Female; Gait Disorders, Neurologic; Humans; Hyperkinesis; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Activity; Movement Disorders; Parkinson Disease; Patient Satisfaction; Quality of Life; Sickness Impact Profile; Surveys and Questionnaires; Treatment Outcome | 2008 |
Motor changes during sertraline treatment in depressed patients with Parkinson's disease*.
Topics: Aged; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Cohort Studies; Depression; Depressive Disorder; Dopamine; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Prospective Studies; Quality of Life; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Severity of Illness Index | 2008 |
Depressive symptoms impacting on health-related quality of life in early Parkinson's disease: results from Chinese L-dopa exposed cohort.
Topics: Aged; Antiparkinson Agents; China; Cohort Studies; Depressive Disorder; Disease Progression; Double-Blind Method; Female; Ganoderma; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Phytotherapy; Quality of Life; Regression Analysis; Surveys and Questionnaires; Treatment Outcome | 2009 |
Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease.
Topics: Antiparkinson Agents; Cells, Cultured; Cerebral Hemorrhage; Corpus Striatum; Depressive Disorder; Gelatin; Graft Survival; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease; Pigment Epithelium of Eye; Pilot Projects; Postoperative Complications; Putamen; Recovery of Function; Stereotaxic Techniques; Treatment Outcome | 2005 |
[Nerve growth factor and the state of serotoninergic system in endogenous depression and mental retardation].
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Blood Platelets; Child; Child, Preschool; Depressive Disorder; Female; Humans; Immunochemistry; In Vitro Techniques; Levodopa; Middle Aged; Nerve Growth Factors; Oxazines; Phenylketonurias; Platelet Aggregation; Receptors, Serotonin; Serotonin; Stimulation, Chemical | 1992 |
63 other study(ies) available for levodopa and Depressive Disorder
Article | Year |
---|---|
Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.
Topics: Aged; Behavior, Addictive; Central Nervous System Stimulants; Depressive Disorder; Dopamine Agents; Dyskinesia, Drug-Induced; Euphoria; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Substance-Related Disorders | 2017 |
Vascular risk factors and depression in Parkinson's disease.
Topics: Aged; Alcohol Drinking; Antiparkinson Agents; Anxiety; Asian People; Cohort Studies; Cross-Sectional Studies; Depressive Disorder; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Obesity; Overweight; Parkinson Disease; Psychiatric Status Rating Scales; Risk Factors; Sex Factors; Vascular Diseases | 2018 |
The relationship between temperament and depression in Parkinson's disease patients under dopaminergic treatment.
Topics: Aged; Antiparkinson Agents; Depressive Disorder; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Surveys and Questionnaires; Temperament | 2019 |
Clinical characteristics and quality of life in Chinese patients with multiple system atrophy.
Topics: Antiparkinson Agents; Anxiety Disorders; Asian People; China; Cognitive Dysfunction; Depressive Disorder; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Quality of Life | 2018 |
Patients' expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach.
Topics: Adult; Aged; Antiparkinson Agents; Apathy; Culture; Deep Brain Stimulation; Depressive Disorder; Disability Evaluation; Female; Humans; Illness Behavior; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Satisfaction; Patient Selection; Prospective Studies; Quality of Life; Subthalamic Nucleus; Symptom Assessment; Treatment Outcome | 2013 |
Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Depression; Depressive Disorder; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires | 2015 |
Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity.
Topics: Antiparkinson Agents; Arm; Art; Benzothiazoles; Brain; Cabergoline; Creativity; Depressive Disorder; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Motor Skills; Obsessive Behavior; Paintings; Parkinson Disease; Pramipexole | 2009 |
Levodopa-induced dyskinesias in spinocerebellar ataxia type 2.
Topics: Antiparkinson Agents; Atrophy; Depressive Disorder; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinsonian Disorders; Rhombencephalon; Spinocerebellar Ataxias | 2010 |
Familial paroxysmal exercise-induced dystonia: atypical presentation of autosomal dominant GTP-cyclohydrolase 1 deficiency.
Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Child; Codon, Nonsense; Depressive Disorder; Dystonia; Exercise; Exons; Family; Female; GTP Cyclohydrolase; Humans; Levodopa; Male; Parkinsonian Disorders; Pedigree; Restless Legs Syndrome | 2010 |
Serotonergic neurotransmission in early Parkinson's disease: a pilot study to assess implications for depression in this disorder.
Topics: Aged; Depressive Disorder; Dopamine Plasma Membrane Transport Proteins; Evoked Potentials, Auditory; Female; Humans; Levodopa; Male; Membrane Transport Proteins; Middle Aged; Parkinson Disease; Pilot Projects; Receptors, Serotonin; Serotonin; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon | 2010 |
Psychiatric symptoms screening in the early stages of Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Anxiety; Cognition; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Levodopa; Male; Mental Disorders; Neuropsychological Tests; Obsessive-Compulsive Disorder; Parkinson Disease; Psychiatric Status Rating Scales; Psychomotor Performance; Psychotic Disorders; Surveys and Questionnaires | 2012 |
Successful subthalamic stimulation in genetic Parkinson's disease caused by duplication of the α-synuclein gene.
Topics: Adult; alpha-Synuclein; Antiparkinson Agents; Deep Brain Stimulation; Depressive Disorder; Dystonia; Executive Function; Female; Follow-Up Studies; Functional Laterality; Gene Duplication; Humans; Levodopa; Neuropsychological Tests; Neurosurgical Procedures; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome | 2012 |
[Extrapyramidal symptoms due to calcinosis cerebri in a patient with unknown primary hypoparathyroidism].
Topics: Basal Ganglia Diseases; Brain Diseases, Metabolic; Calcinosis; Calcitriol; Calcium; Cognition Disorders; Depressive Disorder; Diagnosis, Differential; Dyslipidemias; Female; Gait Disorders, Neurologic; Gluconates; Humans; Hypoparathyroidism; Levodopa; Magnesium; Middle Aged; Syndrome | 2012 |
[Pseudopheochromocytoma in Parkinson disease and depression].
Topics: Adrenal Gland Neoplasms; Antidepressive Agents; Antiparkinson Agents; Catecholamines; Depressive Disorder; Diagnosis, Differential; Dopamine Agonists; Drug Therapy, Combination; Female; Flushing; Homovanillic Acid; Humans; Hypertension; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pheochromocytoma; Vanilmandelic Acid | 2003 |
Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Comorbidity; Depressive Disorder; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychotic Disorders | 2006 |
Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease.
Topics: Affect; Antiparkinson Agents; Cerebral Cortex; Cognition; Combined Modality Therapy; Corpus Striatum; Deep Brain Stimulation; Depressive Disorder; Extinction, Psychological; Female; Humans; Levodopa; Male; Middle Aged; Motivation; Neural Pathways; Neurologic Examination; Neuropsychological Tests; Problem Solving; Reversal Learning; Subthalamic Nucleus | 2006 |
Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
Topics: Affect; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Clomipramine; Clozapine; Delusions; Depressive Disorder; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders | 2007 |
Differential effects of L-dopa and subthalamic stimulation on depressive symptoms and hedonic tone in Parkinson's disease.
Topics: Affect; Antiparkinson Agents; Cognition; Deep Brain Stimulation; Depressive Disorder; Electrodes, Implanted; Female; Humans; Levodopa; Male; Middle Aged; Movement; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Psychomotor Performance; Subthalamic Nucleus | 2006 |
Nighttime sleep problems and daytime sleepiness in Parkinson's disease.
Topics: Adult; Antiparkinson Agents; Demography; Depressive Disorder; Disorders of Excessive Somnolence; Dyskinesias; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Risk Factors; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires | 2008 |
Clinical heterogeneity in newly diagnosed Parkinson's disease.
Topics: Adult; Age Distribution; Age of Onset; Aged; Aged, 80 and over; Anxiety Disorders; Cluster Analysis; Cohort Studies; Comorbidity; Depressive Disorder; Disability Evaluation; Disease Progression; Female; Humans; Immunity, Innate; Levodopa; Male; Middle Aged; Movement Disorders; Netherlands; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Quality of Life | 2008 |
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables.
Topics: Adolescent; Adult; Affective Symptoms; Alcoholism; Comorbidity; Depressive Disorder; Europe; Female; Humans; Levodopa; Male; Middle Aged; Opioid-Related Disorders; Predictive Value of Tests; Psychiatric Status Rating Scales; Psychometrics; Regression Analysis; Severity of Illness Index; Substance-Related Disorders | 2008 |
Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
Topics: Aged; Antipsychotic Agents; Carbidopa; Corpus Striatum; Depressive Disorder; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Metoclopramide; Parkinson Disease, Secondary; Receptors, Dopamine | 1984 |
Animal models used in prediction of antidepressant effects in man.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Depressive Disorder; Drug Evaluation, Preclinical; Drug Synergism; Helplessness, Learned; Humans; Levodopa; Mice; Models, Biological; Motor Activity; Propiophenones; Rats; Reserpine; Tetrabenazine | 1983 |
[Parkinson's disease and neurotransmitters].
Topics: Aged; Depressive Disorder; Dopamine; Humans; Levodopa; Parkinson Disease | 1984 |
Prolactin and growth hormone response to levodopa in affective illness.
Topics: Amitriptyline; Bipolar Disorder; Depressive Disorder; Female; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Menopause; Prolactin | 1983 |
Depression and Parkinson's disease.
Topics: Depressive Disorder; Diagnosis, Differential; Humans; Levodopa; Parkinson Disease; Personality Assessment | 1984 |
Mental disorders in Parkinson's disease after treatment with L-DOPA.
Topics: Aged; Anxiety Disorders; Confusion; Delirium; Dementia; Depressive Disorder; Female; Hallucinations; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease | 1984 |
Pyridoxine and depression: neuroendocrine aspects.
Topics: Depressive Disorder; Dopamine; Drug Synergism; Drug Therapy, Combination; Humans; Levodopa; Male; Prolactin; Pyridoxine; Thyrotropin-Releasing Hormone | 1982 |
Behavioral alterations and the therapy of parkinsonism.
Topics: Bipolar Disorder; Bromocriptine; Dementia; Depressive Disorder; Humans; Levodopa; Mental Processes; Parkinson Disease; Psychoses, Substance-Induced | 1982 |
[Various factors common to the pathogenesis of endogenous depression and chronic alcoholism].
Topics: 11-Hydroxycorticosteroids; Adolescent; Adult; Aged; Alcoholism; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Depressive Disorder; Dexamethasone; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Tryptophan | 1981 |
Anticholinergic effects in a depressed parkinsonian patient.
Topics: Aged; Benztropine; Carbidopa; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoxetine; Humans; Levodopa; Male; Parkinson Disease; Treatment Outcome | 1995 |
Which factors predict cognitive decline in Parkinson's disease?
Topics: Activities of Daily Living; Age of Onset; Aged; Cognition Disorders; Depressive Disorder; Educational Status; Humans; Levodopa; Middle Aged; Movement Disorders; Neuropsychological Tests; Parkinson Disease; Prognosis; Severity of Illness Index; Task Performance and Analysis; Tremor | 1995 |
PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers.
Topics: 5-Hydroxytryptophan; Animals; Brain; Depressive Disorder; Humans; Levodopa; Presynaptic Terminals; Tomography, Emission-Computed | 1994 |
Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease.
Topics: Aged; Dementia; Depression; Depressive Disorder; Disability Evaluation; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Parkinson Disease; Psychomotor Performance; Reference Values; Tremor | 1993 |
Serotonin and Parkinson's disease.
Topics: Basal Ganglia Diseases; Depressive Disorder; Dopamine; Drug Therapy, Combination; Fluoxetine; Humans; Levodopa; Parkinson Disease; Serotonin; Tryptophan | 1993 |
Hypothesis: the bradyphrenia of parkinsonism is a nosological entity.
Topics: Adult; Aged; Aging; Alcohol Drinking; Antiparkinson Agents; Cognition; Cognition Disorders; Depressive Disorder; Ethanol; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Probability; Psychological Tests; Reaction Time | 1993 |
Familial akathisia and depression treated with nefazodone.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Piperazines; Restless Legs Syndrome; Selective Serotonin Reuptake Inhibitors; Triazoles | 1996 |
Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's disease.
Topics: Adult; Aged; Depressive Disorder; Female; Homovanillic Acid; Humans; Kidney Failure, Chronic; Levodopa; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Psychotic Disorders; Renal Dialysis | 1996 |
[Depressive pseudodementia in early Parkinson's disease: lessons from a case with long-term follow-up].
Topics: Aged; Dementia; Depressive Disorder; Female; Humans; Levodopa; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales | 1997 |
Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
Topics: Adult; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Depressive Disorder; Drug Interactions; Female; Humans; Levodopa; Mianserin; Mirtazapine; Parkinson Disease; Psychoses, Substance-Induced; Suicide, Attempted | 1997 |
The effect of long-term levodopa therapy on depression level in de novo patients with Parkinson's disease.
Topics: Depressive Disorder; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Time Factors | 2000 |
[Parkinson's disease].
Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Catechols; Depressive Disorder; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Follow-Up Studies; Humans; Indoles; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nitriles; Parkinson Disease; Parkinsonian Disorders; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders; Time Factors | 2001 |
Some neuroendocrine parameters in bipolar and unipolar depression.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Dopamine beta-Hydroxylase; Female; Growth Hormone; Humans; Levodopa; Middle Aged; Prolactin | 1979 |
Phenelzine treatment of depression in Parkinson's disease.
Topics: Aged; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Parkinson Disease; Phenelzine | 1992 |
ECT and delirium in Parkinson's disease.
Topics: Carbidopa; Combined Modality Therapy; Delirium; Depressive Disorder; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parkinson Disease | 1992 |
Unforeseen beneficial effects of controlled-release levodopa-carbidopa (Sinemet CR)
Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease | 1992 |
The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPS, HIAA, and HVA levels of cerebrospinal fluid.
Topics: Carboxy-Lyases; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Selegiline | 1990 |
Growth hormone dysregulation in children with major depressive disorder.
Topics: Brain; Child; Clonidine; Depressive Disorder; Growth Hormone; Humans; Levodopa; Receptors, Adrenergic, alpha; Receptors, Dopamine | 1990 |
Neuroleptic malignant syndrome without neuroleptics.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan | 1990 |
Clinical and biochemical features of depression in Parkinson's disease.
Topics: Aged; Depressive Disorder; Dexamethasone; Growth Hormone; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Prolactin; Psychomotor Performance; Self Concept; Thyrotropin-Releasing Hormone | 1986 |
Parkinsonism manifesting depression as the first sign.
Topics: Aged; Antidepressive Agents; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1989 |
ECT and Parkinson's disease revisited: a "naturalistic" study.
Topics: Aged; Carbidopa; Confusion; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1989 |
Determination of plasma pyridoxal 5'-phosphate by an enzymatic-high-performance liquid chromatographic procedure.
Topics: Chromatography, High Pressure Liquid; Depressive Disorder; Diet; Humans; Levodopa; Phenelzine; Pyridoxal Phosphate; Streptococcus | 1989 |
A therapeutic approach to tardive dyskinesia.
Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Colitis; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyltyrosines; Middle Aged; Nausea; Paranoid Disorders; Psychomotor Agitation; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, Dopamine; Reserpine; Tetrabenazine; Time Factors | 1985 |
[Depression and Parkinson syndrome].
Topics: Antidepressive Agents; Brain; Depressive Disorder; Drug Therapy, Combination; Humans; Levodopa; Neurotransmitter Agents; Parkinson Disease; Tryptophan | 1986 |
Changes in serum prolactin after electroconvulsive and epileptic seizures.
Topics: Adult; Antipsychotic Agents; Depressive Disorder; Dopamine; Electroconvulsive Therapy; Epilepsy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Schizophrenia | 1987 |
Parkinson's disease, depression, and the on-off phenomenon.
Topics: Bromocriptine; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease | 1989 |
[Therapeutic strategies and tactics in parkinsonism].
Topics: Amantadine; Antidepressive Agents; Antiparkinson Agents; Benserazide; Carbidopa; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Motor Skills; Parkinson Disease; Selegiline; Sleep Initiation and Maintenance Disorders | 1986 |
L-5-hydroxytryptophan alone and in combination with a peripheral decarboxylase inhibitor in the treatment of depression.
Topics: 5-Hydroxytryptophan; Adult; Aged; Benserazide; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Psychological Tests; Retrospective Studies | 1988 |
Mood swings associated with the 'on-off' phenomenon in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Parkinson Disease; Parkinson Disease, Secondary | 1987 |
Response of tardive and L-dopa-induced dyskinesias to antidepressants.
Topics: Aged; Antidepressive Agents; Depressive Disorder; Desipramine; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Trazodone | 1987 |
Dexamethasone suppression test in Parkinson's disease.
Topics: Aged; Depressive Disorder; Dexamethasone; Female; Humans; Hydrocortisone; Levodopa; Male; Parkinson Disease | 1987 |
Major depression and carbon monoxide-induced parkinsonism: diagnosis, computerized axial tomography, and response to L-dopa.
Topics: Adult; Antidepressive Agents, Tricyclic; Carbon Monoxide Poisoning; Depressive Disorder; Globus Pallidus; Humans; Levodopa; Male; Necrosis; Parkinson Disease, Secondary; Tomography, X-Ray Computed | 1985 |